DEPLOYDatabase

Partnership

ABLE Labs x Johns Hopkins University

ABLE Labs and Johns Hopkins University collaborating on a next-generation AI-based drug evaluation platform using organoid cultivation and fully automated drug efficacy testing. The partnership targets growing demand for organoid-based non-clinical verification following FDA roadmap to eliminate mandatory animal testing.

development · Active · just announced


Machine-readable surfaces

d45ba9eb-cc33-483e-9403-cfd2a92670fa
Type
development
Status
Activejust announced
Announced
2026-06-01
3 months ago
Active for
3 months

Who’s involved

ABLE Labsco developer

South Korean laboratory automation robotics company founded in 2021 by Sang Shin, developing liquid handling robots and [self-driving lab](https://en.wikipedia.org/wiki/Self-driving_laboratory) platforms. Its flagship product NOTABLE automates pipetting workflows for bio experiments, with ~70 units deployed across 50+ research institutions. The company is building AI-integrated autonomous laboratory systems and has expanded into semiconductor, chemical, cosmetics, and battery quality testing automation.

HQSeoul, South Koreaablelabs.ai0 partnerships

Off-registry parties

  • Johns Hopkins University · co developer

Related partnerships

Recent partnerships of the same kind

Sources (1)

  1. https://www.msn.com/ko-kr/일반/일반/바이오-실험-전문기업-에이블랩스-존스홉킨스와-차세대-ai기반-약물평가-플랫폼-협업/ar-AA1xylbm

Deploy Watch

Track this partnership.

We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.